NCT07615257 Managing Psychological Distress Through Mindfulness-based CBT to Evaluate Its Effectiveness on Self-compassion Among Psoriasis Patients:The Mediating Role of Mental Health Locus of Control
| NCT ID | NCT07615257 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Islamia University of Bahawalpur |
| Condition | Psoriasis |
| Study Type | INTERVENTIONAL |
| Enrollment | 128 participants |
| Start Date | 2025-02-05 |
| Primary Completion | 2026-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 128 participants in total. It began in 2025-02-05 with a primary completion date of 2026-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Your research study is about evaluating the effectiveness of \*\*Mindfulness-Based Cognitive Therapy (MBCT)\*\* in reducing psychological distress among psoriasis patients and improving their self-compassion and Mental Health Locus of Control (MHLC). The study highlights that psoriasis patients often suffer not only from physical symptoms but also from psychological problems such as stress, anxiety, depression, self-judgment, and low self-compassion. Traditional treatments mainly focus on physical symptoms and may not fully address these emotional and psychological difficulties. To address this gap, the study proposes MBCT as a psychological intervention that combines mindfulness practices with cognitive therapy techniques. MBCT helps patients become more self-aware, reduce negative thinking, and develop self-compassion without self-judgment. The research also explores MHLC, which refers to how much control individuals believe they have over their health outcomes. The study aims to investigate whether MBCT can: * Reduce psychological distress, anxiety, depression, and stress levels * Improve self-compassion among psoriasis patients * Shift patients' locus of control from external to internal * Enhance emotional well-being and coping mechanisms The research follows a quantitative experimental design conducted in phases. Initially, baseline levels of distress, MHLC, and self-compassion will be assessed. Later, MBCT interventions will be implemented and evaluated for effectiveness. Overall, the study seeks to contribute to integrated psoriasis care by emphasizing the importance of psychological health alongside physical treatment, ultimately improving patients' quality of life and therapeutic outcomes.
Eligibility Criteria
Inclusion Criteria: * Diagnosed psoriasis patients * Age between 18 and 65 years * Both male and female participants * Participants willing to provide informed consent * Participants experiencing psychological distress Exclusion Criteria: * Under the age of 18 years will be excluded. * Patients with severe psychiatric disorders * Patients currently receiving other psychological therapies * Patients with serious medical or neurological conditions * Participants unwilling to continue the intervention sessions * Patients with cognitive impairment affecting participation
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07615257 clinical trial?
This trial is open to participants of all sexes, aged 25 Years or older, up to 75 Years, studying Psoriasis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07615257 currently recruiting?
Yes, NCT07615257 is actively recruiting participants. Contact the research team at rafiaghaffar1@gmail.com for enrollment information.
Where is the NCT07615257 trial being conducted?
This trial is being conducted at Rahim Yar Khan, Pakistan.
Who is sponsoring the NCT07615257 clinical trial?
NCT07615257 is sponsored by Islamia University of Bahawalpur. The trial plans to enroll 128 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.